Global Neisseria meningitidis Vaccine Pipeline H2 2016 2017

Neisseria meningitidis Pipeline Review H2 2016 report provides comprehensive information on the
therapeutics under development for Neisseria meningitidis, complete with analysis by stage of
development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule
type. The report also covers the descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases. Additionally, the report
provides an overview of key players involved in therapeutic development for Neisseria meningitidis
and features dormant and discontinued projects.
Inquire for Complete PDF Report @
http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=743411
Description of Report:
Neisseria meningitidis Pipeline Review H2 2016 report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and
information sourced from proprietary databases, company/university websites, clinical trial
registries, conferences, SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources. Drug profiles featured in the
report undergoes periodic review following a stringent set of processes to ensure that all the profiles
are updated with the latest set of information. Additionally, various dynamic tracking processes
ensure that the most recent developments are captured on a real time basis. The report helps in
identifying and tracking emerging players in the market and their portfolios, enhances decision
making capabilities and helps to create effective counter strategies to gain competitive advantage.
The report provides a snapshot of the global therapeutic landscape of Neisseria meningitidis
Key Companies Analyzed In Report:
Beijing Minhai Biotechnology, Beijing Tiantan Biological Products, Biological E. Limited, China
National Pharmaceutical Group, GlaxoSmithKline, ImmunoBiology, JN-International Medical
Corporation, MGB Biopharma, Panacea Biotec, Pfizer, Sanofi Pasteur, Serum Institute of India
Limited, Wellstat Vaccines
The report reviews pipeline therapeutics for Neisseria meningitidis by companies and
universities/research institutes based on information derived from company and industry-specific
sources. The report covers pipeline products based on various stages of development ranging from
pre-registration till discovery and undisclosed stages. The report features descriptive drug profiles
for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing
and collaboration details & other developmental activities. The report reviews key player’s involved
Neisseria meningitidis therapeutics and enlists all their major and minor projects. The report
assesses Neisseria meningitidis therapeutics based on drug target, mechanism of action (MoA),
route of administration (RoA) and molecule type. The report summarizes all the dormant and
discontinued pipeline projects. The report reviews latest news related to pipeline therapeutics for
Neisseria meningitidis
Get Discount On Report @ http://www.reportsnreports.com/contacts/discount.aspx?name=743411
Gain strategically significant competitor information, analysis, and insights to formulate effective
R&D strategies. Identify emerging players with potentially strong product portfolio and create